These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9423822)

  • 1. Multiple myeloma associated with serum amino acid disturbance and high output cardiac failure.
    Kuribayashi N; Matsuzaki H; Hata H; Yoshida M; Sonoki T; Nagasaki A; Kimura T; Okamoto K; Kurose M; Tsuda H; Takatsuki K
    Am J Hematol; 1998 Jan; 57(1):77-81. PubMed ID: 9423822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amino acid disturbance in multiple myeloma with hyperammonemia.
    Matsuzaki H; Hata H; Sonoki T; Matsuno F; Kuribayashi N; Yoshida M; Nagasaki A; Murata H; Fujiyama S; Takatsuki K
    Int J Hematol; 1995 Apr; 61(3):131-7. PubMed ID: 7599324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of serum angiogenic factors in a young multiple myeloma patient with high-output cardiac failure.
    Sasaki K; Yamashita K; Miyoshi T; Furukawa Y; Kimura T; Kita T; Ichinohe T; Ishikawa T; Sasada M; Uchiyama T
    Int J Hematol; 2007 Jul; 86(1):72-6. PubMed ID: 17675271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperammonemia in multiple myeloma.
    Matsuzaki H; Uchiba M; Yoshimura K; Yoshida M; Akahoshi Y; Okazaki K; Takatsuki K
    Acta Haematol; 1990; 84(3):130-4. PubMed ID: 2123062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary plasma cell leukemia complicated with high-output cardiac failure and hyperammonemia].
    Nakahashi E; Kuribayashi N; Tsuji N; Kawaguchi T; Hata H; Matsuzaki H; Shimizu K; Takatsuki K
    Rinsho Ketsueki; 1994 Aug; 35(8):756-60. PubMed ID: 7933562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinicopathological study of multiple myeloma associated with hyperammonemia].
    Fujii S; Fukuda S; Sezaki T; Murakami M
    Rinsho Ketsueki; 1998 Jan; 39(1):27-33. PubMed ID: 9492550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-output Cardiac Failure: A Forgotten Phenotype in Clinical Practice.
    de Ávila DX; Villacorta H; de Andrade Martins W; Mesquita ET
    Curr Cardiol Rev; 2022; 18(1):e050821195319. PubMed ID: 34353268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple myeloma and hyperammonemic encephalopathy: review of 27 cases.
    Lora-Tamayo J; Palom X; Sarrá J; Gasch O; Isern V; Fernández de Sevilla A; Pujol R
    Clin Lymphoma Myeloma; 2008 Dec; 8(6):363-9. PubMed ID: 19064403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia].
    Kozuka T; Fukuda S; Imai T; Sezaki T
    Rinsho Ketsueki; 2000 Nov; 41(11):1220-5. PubMed ID: 11193443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia.
    Matsuzaki H; Matsuno F; Yoshida M; Hata H; Okazaki K; Takatsuki K
    Intern Med; 1992 Mar; 31(3):339-43. PubMed ID: 1611184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splanchnic circulation and metabolism in patients with acute liver failure.
    Clemmesen O
    Dan Med Bull; 2002 Aug; 49(3):177-93. PubMed ID: 12238280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rapid improvement of hyperammonemic encephalopathy by bortezomib treatment in IgD-type multiple myeloma].
    Esaki M; Ishii K; Azuma Y; Tsubokura Y; Yoshimura H; Hotta M; Nakanishi T; Fujita S; Nakaya A; Satake A; Ito T; Nomura S
    Rinsho Ketsueki; 2016 Jul; 57(7):854-8. PubMed ID: 27498728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperammonemia: an unusual presenting feature of multiple myeloma.
    Shah AS; Shetty N; Jaiswal S; Mehta BC
    Indian J Med Sci; 2005 Jan; 59(1):24-7. PubMed ID: 15681889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperammonemic encephalopathy as the presenting feature of a relapsing multiple myeloma].
    Issa N; Blondeau B; Dimicoli-Salazar S; Marit G; Morlat P; Camou F
    Rev Med Interne; 2016 Aug; 37(8):567-9. PubMed ID: 26681106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Non-secretory primary plasma cell leukemia with hyperammonemia].
    Kawano F; Tsukamoto A; Satoh M; Sanada I; Shido T; Miura K; Murakami T; Kaneko H; Takeya M; Matsuzaki H
    Rinsho Ketsueki; 1991 Apr; 32(4):399-403. PubMed ID: 2067085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple Myeloma with Hyperammonemia Treated with Novel Agents: A Case Series of Three Patients.
    Nakamura H; Takada K; Murase K; Ikeda H; Iyama S; Manabe T; Kobune M
    Intern Med; 2023 Mar; 62(5):775-778. PubMed ID: 35871579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Massive ascites as an initial sign, plasmacytoma of the cervical supine, and hyperammonemic consciousness disturbance in a patient with biclonal type multiple myeloma].
    Ohmoto A; Kohno M; Yasukawa K; Matsuyama R
    Rinsho Ketsueki; 1996 Apr; 37(4):346-51. PubMed ID: 8847807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous double hemodialysis for the control of refractory hyperammonemia.
    Brucculeri M; Gabbard W; Masson J; Jooma N
    Int J Artif Organs; 2013 Feb; 36(2):135-8. PubMed ID: 23404638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of hyperammonemia presented in a patient with multiple myeloma].
    Sjölund I; Kragsbjerg P
    Lakartidningen; 2021 Jun; 118():. PubMed ID: 34151998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and clinical characteristics of a high cardiac output state in patients with multiple myeloma.
    McBride W; Jackman JD; Grayburn PA
    Am J Med; 1990 Jul; 89(1):21-4. PubMed ID: 2368788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.